The benefits of GLP-1 drugs beyond obesity. science.org/doi/10.1126/sc…

A new comprehensive review on G.lP-1 physiology in the #weightloss era #obesity from Prof Holst NNF Center for Basic Metabolic Research (CBMR) Nature Metabolism nature.com/articles/s4225…

Comprehensive management of multiple risk factors important to reduce risk of heart failure in people with T2 diabetes diabetesjournals.org/care/article/d… ADA Professional Publications

SELECT Trial-In people with overweight/obesity & CVD Baseline hsCRP was a prognostic biomarker for MACE Greater weight loss associated with greater hsCRP ⬇️ Semaglutide significantly ⬇️ MACE across all baseline hsCRP and clinical subgroups. atherosclerosis-journal.com/article/S0021-…

Happy to share the review of article regarding Image-guided PCI, published in JACC Asia supported by the KSIC (Korea Society of Interventional Cardiology) and the IPOP (Imaging and Physiology with Cardiovascular Disease) jacc.org/doi/10.1016/j.…

Large-bore access management is crucial in structural heart interventions. Check out our latest review in CircInterventions to explore tips to prevent vascular complications! ahajournals.org/doi/10.1161/CI… FRANCESCO BURZOTTA Francesco Bianchini Cristina Aurigemma Andrea Zito Emiliano Bianchini Mattia Lunardi

Our analysis with Office for National Statistics (ONS) Health Survey for England data 2013-2019 An estimated 30·2% of adults had undiagnosed T2 diabetes in England (~1 million people) 11·5% had non-diabetic hyperglycaemia (>5 M). Clare Hambling thelancet.com/action/showPdf… Led by Emma Campbell & Ellie Macey

A retrospective observational follow up over ~2.1 years revealed better preservation of kidney function with SGLT2i vs. GLP-1RA #T2D Diabetologia link.springer.com/article/10.100…

Exited to share this case report publication led by ⁦Nawaz Z Safdar⁩ on renal denervation for the treatment of resistant hypertension . Special Thanks to ⁦Syed Ali Naqvi⁩ and @Ali.ali casereports.bmj.com/content/17/8/e…

Excellent work by Nawaz Z Safdar and Usman Shah writing this up. New ESC guidelines 👇🏽 This is exactly the algorithm we followed to treat this patient. It is unclear why she had a super-response. She had syncope/dizziness after hospital discharge. Andrew SP Sharp #CardioTwitter

Statistics session at #ESCCongress 2024. P values are here to stay but not dichotomy, win ratio is important as sec analysis. Chat GPT in clinical trials are closer to human brain and may surpass on chat gpt 4! Giuseppe Biondi-Zoccai Prof Chris P Gale Dr. Deepak L. Bhatt Thank you for a great session!

A review of 3 trials in persons with type 2 diabetes, demonstrated consistent cardiovascular and kidney benefits of GLP-1 receptor agonists regardless of SGLT2 inhibitor use Circulation ahajournals.org/doi/10.1161/CI… #T2D #heartdisease #heartfailure #CKD

Can you stop beta blockers post MI when the LV is normal ? The Abyss trial suggests you should NOT stop the beta blocker (with no improvement in quality of life if you do stop it)

Whoaaaa! #FINEARTS_HF

Congratulations to my #PhD student Usman Shah University of Lincoln CardioRenal Group on hosting the workshop 'Designing & testing an innovative approach to maximise opportunities to optimise care for #type2diabetes patients who develop #acutecoronarysyndrome at #ESCCongress2024 last weekend 🥳🥳

Treatment with SGLT2 inhibitors after myocardial infarction in people with T2 diabetes associated with a lower rate of cardiovascular events. SWEDEHEART study thelancet.com/journals/lanep…

🔥🔥🔥 An essential resource! Outstanding review on steroidal versus nonsteroidal MRA in HF. All trials, mechanisms, profiles. Andrew J Sauer MD Harriette Van Spall, MD MPH Andrew P. Ambrosy, MD #JACCHF JACC Journals jacc.org/doi/10.1016/j.…

I still hear some say that ultrasound guidance for femoral arterial access isn't necessary & doesn't reduce complications. This CircInterventions meta-analysis suggests otherwise. You need to develop proficiency with U/S to get the best results ahajournals.org/doi/full/10.11…